Barbanti, Piero http://orcid.org/0000-0002-5670-3755
Egeo, Gabriella
Proietti, Stefania
d’Onofrio, Florindo
Aurilia, Cinzia
Finocchi, Cinzia
Di Clemente, Laura
Zucco, Maurizio
Doretti, Alberto
Messina, Stefano
Autunno, Massimo
Ranieri, Angelo
Carnevale, Antonio
Colombo, Bruno
Filippi, Massimo
Tasillo, Miriam
Rinalduzzi, Steno
Querzani, Pietro
Sette, Giuliano
Forino, Lorenzo
Zoroddu, Francesco
Robotti, Micaela
Valenza, Alessandro
Camarda, Cecilia
Borrello, Laura
Aguggia, Marco
Viticchi, Giovanna
Tomino, Carlo
Fiorentini, Giulia
Orlando, Bianca
Bonassi, Stefano
Torelli, Paola
,
Funding for this research was provided by:
Institutional Funding Ricerca Corrente (IRCCS San Raffaele)
Fondazione Italiana Cefalee
Article History
Received: 4 December 2023
Accepted: 14 February 2024
First Online: 7 March 2024
Change Date: 6 August 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40120-024-00648-z
Declarations
:
: Piero Barbanti received travel grants, honoraria for advisory boards, speaker panels or clinical investigation studies from Abbvie, Alder, Allergan, Amgen, Angelini, Assosalute, Bayer, Biohaven, ElectroCore, Eli-Lilly, Fondazione Ricerca e Salute, GSK, Lundbeck, Lusofarmaco, 1MED, MSD, New Penta, Noema Pharma, Novartis, Pfizer, Stx-Med, Teva, Visufarma, Zambon and serves as President with Italian Association of Headache Sufferers. Gabriella Egeo received travel grants and honoraria from Eli Lilly, Novartis, New Penta, Lundbeck and Ecupharma. Cinzia Aurilia received travel grants from FB-Health, Lusofarmaco, Almirall, Eli Lilly Novartis and Teva. Florindo d'Onofrio received travel grant, honoraria as a speaker or for partecipating in advisory boards from Novartis, Teva, Neopharmed Gentili, Qbgroupsrl, K link srl and Eli Lilly. Cinzia Finocchi received grants and honoraria from Novartis, Teva, Lilly, Lundbeck, Pfizer. Angelo Ranieri received speaker honoraria from TEVA, Ely Lilly, AIM Group. Antonio Carnevale has no disclosures to declare. Bruno Colombo has received congress fee reimbursements from Teva, Novartis, Pfizer. Massimo Filippi is Editor-in-Chief of the<i> Journal of Neurology</i>; received compensation for consulting services and/or speaking activities from Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA). Alessandro Valenza received grants from Teva, Lilly, Lundbeck, Pfizer. Marco Aguggia received grants from Novartis and Lilly. Paola Torelli received travel grants and honoraria from Allergan, Teva, Eli Lilly and Novartis. Stefania Proietti, Laura Di Clemente, Maurizio Zucco, Alberto Doretti, Stefano Messina, Massimo Autunno, Miriam Tasillo, Steno Rinalduzzi, Pietro Querzani, Giuliano Sette, Lorenzo Forino, Francesco Zoroddu, Micaela Robotti, Cecilia Camarda, Laura Borrello, Giovanna Viticchi, Carlo Tomino, Giulia Fiorentini, Bianca Orlando and Stefano Bonassi have no disclosures to declare.
: Eligible participants provided informed consent to participate in the study and were subsequently enrolled. The study was conducted in accordance with principles outlined in the Declaration of Helsinki. The study protocol received approval by IRCCS San Raffaele Roma Institutional Review Board (RP 19/26) and mutually recognized by other local institutional review boards.